Capstone Investment Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$397K Buy
+4,612
New +$414K ﹤0.01% 1252
2024
Q2
Sell
-5,747
Closed -$308K 2226
2024
Q1
$308K Buy
+5,747
New +$309K ﹤0.01% 1822
2017
Q2
Sell
-27,677
Closed -$819K 740
2017
Q1
$819K Buy
+27,677
New +$755K 0.02% 474
2016
Q4
Sell
-13,300
Closed -$300K 1005
2016
Q3
$300K Sell
13,300
-5,339
-29% -$125K 0.01% 605
2016
Q2
$444K Sell
18,639
-2,394
-11% -$57.4K 0.01% 493
2016
Q1
$499K Buy
+21,033
New +$514K 0.02% 423

Other funds holding GMED

Capstone Investment Advisors's GMED Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Globus Medical (GMED) in Q1 2026: 4,612 shares worth $397K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in GMED as recently as Q1 2024.

Capstone Investment Advisors first reported a position in GMED in Q1 2016 and has held it in 6 quarters since. The position peaked at $819K in Q1 2017. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Capstone Investment Advisors held 4,612 shares of Globus Medical worth $397K as of Q1 2026.
  • Globus Medical was a new Capstone Investment Advisors position in Q1 2026.
  • Globus Medical made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1252 holding.
  • Capstone Investment Advisors first reported a position in Globus Medical in Q1 2016 and has held it in 6 quarters since.
  • Capstone Investment Advisors's Globus Medical position peaked at $819K in Q1 2017.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.